222 related articles for article (PubMed ID: 15630047)
1. Angiotensin II and the endothelium: diverse signals and effects.
Watanabe T; Barker TA; Berk BC
Hypertension; 2005 Feb; 45(2):163-9. PubMed ID: 15630047
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin, bradykinin and the endothelium.
Dimitropoulou C; Chatterjee A; McCloud L; Yetik-Anacak G; Catravas JD
Handb Exp Pharmacol; 2006; (176 Pt 1):255-94. PubMed ID: 16999222
[TBL] [Abstract][Full Text] [Related]
3. [Diversity in mechanism of angiotensin II production and application of the suppressive agents].
Miyazaki T
Nihon Yakurigaku Zasshi; 2008 Mar; 131(3):178-9. PubMed ID: 18421843
[No Abstract] [Full Text] [Related]
4. How to explain the differences between renin angiotensin system modulators.
Levy BI
Am J Hypertens; 2005 Sep; 18(9 Pt 2):134S-141S. PubMed ID: 16125050
[TBL] [Abstract][Full Text] [Related]
5. Effect of angiotensin II type 1 receptor antagonism on endothelial function: role of bradykinin and nitric oxide.
Landmesser U; Drexler H
J Hypertens Suppl; 2006 Mar; 24(1):S39-43. PubMed ID: 16601572
[TBL] [Abstract][Full Text] [Related]
6. What is the role of angiotensin-receptor blockade in cardiovascular protection?
Cohn JN
Am Heart J; 2006 Nov; 152(5):859.e1-8. PubMed ID: 17070145
[TBL] [Abstract][Full Text] [Related]
7. Local expression and pathophysiological role of renin-angiotensin in the blood vessels and heart.
Dzau VJ
Basic Res Cardiol; 1993; 88 Suppl 1():1-14. PubMed ID: 8395169
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin-converting enzyme and vascular remodeling.
Heeneman S; Sluimer JC; Daemen MJ
Circ Res; 2007 Aug; 101(5):441-54. PubMed ID: 17761934
[TBL] [Abstract][Full Text] [Related]
9. Collagen network of the myocardium: function, structural remodeling and regulatory mechanisms.
Weber KT; Sun Y; Tyagi SC; Cleutjens JP
J Mol Cell Cardiol; 1994 Mar; 26(3):279-92. PubMed ID: 8028011
[TBL] [Abstract][Full Text] [Related]
10. The renin-angiotensin system and vascular function. The role of angiotensin II, angiotensin-converting enzyme, and alternative conversion of angiotensin I.
Roks A; Buikema H; Pinto YM; van Gilst WH
Heart Vessels; 1997; Suppl 12():119-24. PubMed ID: 9476561
[TBL] [Abstract][Full Text] [Related]
11. Local action of the renin angiotensin system in the porcine ophthalmic circulation: effects of ACE-inhibitors and angiotensin receptor antagonists.
Meyer P; Flammer J; Lüscher TF
Invest Ophthalmol Vis Sci; 1995 Mar; 36(3):555-62. PubMed ID: 7890486
[TBL] [Abstract][Full Text] [Related]
12. Reinventing the ACE inhibitors: some old and new implications of ACE inhibition.
Hanif K; Bid HK; Konwar R
Hypertens Res; 2010 Jan; 33(1):11-21. PubMed ID: 19911001
[TBL] [Abstract][Full Text] [Related]
13. ACE-Triggered Hypertension Incites Stroke: Genetic, Molecular, and Therapeutic Aspects.
Vasudeva K; Balyan R; Munshi A
Neuromolecular Med; 2020 Jun; 22(2):194-209. PubMed ID: 31802381
[TBL] [Abstract][Full Text] [Related]
14. [The role of the selective blocking of angiotensin II receptors in the treatment of cardiovascular diseases].
Carnovali M
Clin Ter; 2001; 152(2):103-6. PubMed ID: 11441521
[TBL] [Abstract][Full Text] [Related]
15. Role of angiotensin receptor blockers in the prevention and treatment of arrhythmias.
Garg S; Narula J; Marelli C; Cesario D
Am J Cardiol; 2006 Mar; 97(6):921-5. PubMed ID: 16516603
[TBL] [Abstract][Full Text] [Related]
16. The renin angiotensin system in bypass graft surgery.
Borland JA; Chester AH; Yacoub MH
Curr Opin Cardiol; 2000 Nov; 15(6):371-7. PubMed ID: 11198618
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II: biosynthesis, molecular recognition, and signal transduction.
Riordan JF
Cell Mol Neurobiol; 1995 Dec; 15(6):637-51. PubMed ID: 8719034
[TBL] [Abstract][Full Text] [Related]
18. The role of the renin-angiotensin-aldosterone system in cardiovascular progenitor cell function.
Qian C; Schoemaker RG; van Gilst WH; Roks AJ
Clin Sci (Lond); 2009 Feb; 116(4):301-14. PubMed ID: 19138171
[TBL] [Abstract][Full Text] [Related]
19. Combination therapy with ACE inhibitors and angiotensin II receptor blockers to halt progression of chronic renal disease: pathophysiology and indications.
Wolf G; Ritz E
Kidney Int; 2005 Mar; 67(3):799-812. PubMed ID: 15698420
[TBL] [Abstract][Full Text] [Related]
20. [Effect of cilazapril, a converting enzyme inhibitor, on cardiovascular hypertrophy in the hypertensive patient].
Sesin J; Tamargo J
Medicina (B Aires); 1996; 56(1):75-84. PubMed ID: 8734937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
